StemCells (STEM) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts STEM Hot Sheet
Price: $1.66 -4.05%
EPS Growth %: +27.6%
Financial Fact:
Interest expense: -128
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +27.6%
Financial Fact:
Interest expense: -128
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
StemCells (NASDAQ: STEM) reported Q3 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $883 million versus the consensus estimate of $220 million.
For earnings history and earnings-related data on StemCells (STEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance
- Employers Holdings (EIG) Misses Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
